Redhawk Wealth Advisors
PFE icon

Redhawk Wealth Advisors’s Pfizer PFE Stock Holding History

Redhawk Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.34M Buy
47,090
+282
+0.6% +$7.5K 0.14% 143
2026
Q2 		$1.13M Sell
46,808
-3,139
-6% -$82.1K 0.11% 168
2026
Q1 		$1.4M Sell
49,947
-1,858
-4% -$49.5K 0.15% 146
2025
Q4 		$1.29M Sell
51,805
-1,131
-2% -$28.5K 0.14% 142
2025
Q3 		$1.35M Buy
52,936
+5,439
+11% +$134K 0.16% 126
2025
Q2 		$1.15M Buy
+47,497
New +$1.11M 0.14% 134
2025
Q1 		– Sell
-7,971
Closed -$211K – 323
2024
Q4 		$211K Sell
7,971
-895
-10% -$24.3K 0.03% 279
2024
Q3 		$257K Sell
8,866
-1,430
-14% -$41.7K 0.04% 259
2024
Q2 		$288K Sell
10,296
-197
-2% -$5.42K 0.04% 231
2024
Q1 		$291K Sell
10,493
-416
-4% -$11.5K 0.05% 254
2023
Q4 		$314K Buy
10,909
+538
+5% +$16.3K 0.06% 217
2023
Q3 		$344K Buy
10,371
+1,682
+19% +$59.5K 0.11% 146
2023
Q2 		$319K Buy
8,689
+3,169
+57% +$123K 0.1% 150
2023
Q1 		$225K Sell
5,520
-14,608
-73% -$631K 0.08% 161
2022
Q4 		$1.03M Buy
20,128
+14,970
+290% +$718K 0.4% 75
2022
Q3 		$226K Buy
5,158
+81
+2% +$3.94K 0.1% 143
2022
Q2 		$266K Sell
5,077
-140
-3% -$7.13K 0.12% 135
2022
Q1 		$270K Sell
5,217
-3,182
-38% -$165K 0.07% 171
2021
Q4 		$496K Buy
8,399
+797
+10% +$39.5K 0.13% 115
2021
Q3 		$327K Sell
7,602
-3,850
-34% -$171K 0.09% 158
2021
Q2 		$448K Buy
11,452
+2,913
+34% +$113K 0.1% 154
2021
Q1 		$309K Sell
8,539
-4,142
-33% -$147K 0.08% 170
2020
Q4 		$467K Buy
12,681
+4,555
+56% +$167K 0.12% 128
2020
Q3 		$283K Buy
8,126
+293
+4% +$10.3K 0.08% 171
2020
Q2 		$243K Buy
+7,833
New +$266K 0.08% 158
2019
Q3 		– Sell
-4,429
Closed -$182K – 348
2019
Q2 		$182K Buy
+4,429
New +$176K 0.07% 145

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Redhawk Wealth Advisors's PFE Position: Q3 2026 in Review

Redhawk Wealth Advisors increased its Pfizer (PFE) stake by 0.6% in Q3 2026, buying an estimated $7.5K and bringing the position to 47,090 shares worth $1.34M. The position accounts for 0.14% of the portfolio, ranked #143.

Redhawk Wealth Advisors first reported a position in PFE in Q2 2019 and has held it in 26 quarters since. The position peaked at $1.4M in Q1 2026. 881 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Redhawk Wealth Advisors held 47,090 shares of Pfizer worth $1.34M as of Q3 2026.
  • Redhawk Wealth Advisors bought 282 Pfizer shares in Q3 2026, an estimated $7.5K.
  • Pfizer made up 0.14% of Redhawk Wealth Advisors's portfolio in Q3 2026, its #143 holding.
  • Redhawk Wealth Advisors first reported a position in Pfizer in Q2 2019 and has held it in 26 quarters since.
  • Redhawk Wealth Advisors's Pfizer position peaked at $1.4M in Q1 2026.
  • 881 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.